You are here

  • Home
  • Archive
  • Volume 76, Issue 2
  • Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study

Citation Tools

Article menu

Download PDFPDF

Clinical and epidemiological research
Extended report
Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Park W, Yoo DH, Miranda P, et al
Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study
Annals of the Rheumatic Diseases 2017;76:346-354.